Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVA II moisturiser trial for relapse prevention in pediatric atopic dermatitis
2022-501184-41-00Phase 4Completed
- Sponsor
- ACO
- Start
- Feb 2023
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of urea + lactic acid and Essex cream in atopic dermatitis (AD) (2 arms), sponsored by ACO. Primary endpoint: Relapse of atopic eczema. Started Feb 2023; status: completed.
02
Drugs
urea + lactic acidEssex cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2022-501184-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501184-41-00.